Bordet, S., Grasso, L., Udovin, L., Chevalier, G., Otero-Losada, M., Capani, F., & Pérez-Lloret, S. (2025). An open‐label, non‐randomized, drug‐repurposing study to explore the clinical effects of Angiotensin II Type 1 (AT1) receptor antagonists on anxiety and depression in Parkinson's Disease. International Parkinson and Movement Disorder Society.
Cita Chicago Style (17a ed.)Bordet, Sofía, Lina Grasso, Lucas Udovin, Guenson Chevalier, Matilde Otero-Losada, Francisco Capani, y Santiago Pérez-Lloret. An Open‐label, Non‐randomized, Drug‐repurposing Study to Explore the Clinical Effects of Angiotensin II Type 1 (AT1) Receptor Antagonists on Anxiety and Depression in Parkinson's Disease. International Parkinson and Movement Disorder Society, 2025.
Cita MLA (8a ed.)Bordet, Sofía, et al. An Open‐label, Non‐randomized, Drug‐repurposing Study to Explore the Clinical Effects of Angiotensin II Type 1 (AT1) Receptor Antagonists on Anxiety and Depression in Parkinson's Disease. International Parkinson and Movement Disorder Society, 2025.